Literature DB >> 19429358

In vitro and in vivo antimicrobial activities of seeds of Caesalpinia bonduc (Lin.) Roxb.

Tasleem Arif1, T K Mandal, Naresh Kumar, J D Bhosale, Archana Hole, G L Sharma, M M Padhi, G S Lavekar, Rajesh Dabur.   

Abstract

AIM OF THE STUDY: Caesalpinia bonduc (Lin.) Roxb. is a known drug in Ayurveda to treat various diseases specifically tumors, cysts and cystic fibrosis (CF). The aim of this study was to assess in vitro as well as in vivo antimicrobial activity of Caesalpinia bonduc seeds.
MATERIALS AND METHODS: The in vitro antimicrobial activities of seed coat and seed kernel extracts were investigated by microbroth dilution assay. In vivo activities of hydro-alcoholic extracts were investigated in rat models of chronic Pseudomonas aeruginosa pneumonia mimicking that in patients with cystic fibrosis.
RESULTS: Various extracts of plant seeds exhibited in vitro antimicrobial activities in a range of 22-350 microg/ml. The extracts also showed activity against methicillin resistant (MR) Staphylococcus aureus and ampicillin resistant (AR) Pseudomonas aeruginosa as in the sensitive strains. In rat model of chronic Pseudomonas aeruginosa pneumonia, hydro-alcoholic extracts of Caesalpinia bonduc seed kernel (CBSK) and Caesalpinia bonduc seed coat (CBSC) were injected subcutaneously in the test groups of animals. The control groups were treated with cortisone and saline. Two weeks after challenge with Pseudomonas aeruginosa, the CBSK treated animals showed a significant bacterial clearance from the lungs (P<0.04) and less severe incidence of lung abscess (P<0.05).
CONCLUSION: Results showed that Caesalpinia bonduc may have the potential to be promising natural medicine, with other forms of treatments, for CF patients with chronic Pseudomonas aeruginosa lung infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429358     DOI: 10.1016/j.jep.2009.02.040

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Caesalpinbondin A, a Novel Diterpenoid Lactone With an Unprecedented Carbon Skeleton from the Seeds of Caesalpinia bonduc.

Authors:  Dong-Qing Fei; Hui-Hong Li; Xiao-Han Chen; Wen-Bo Cui; Zong-Ping Zhang; Xiao-Qing Zhan; Mei-Jie Wang; Feng-Ming Qi; Zhan-Xin Zhang; Er-Wei Li
Journal:  Front Chem       Date:  2022-06-24       Impact factor: 5.545

2.  In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa.

Authors:  Ana Carolina A V Kayano; Stefanie C P Lopes; Fernanda G Bueno; Elaine C Cabral; Wanessa C Souza-Neiras; Lucy M Yamauchi; Mary A Foglio; Marcos N Eberlin; João Carlos P Mello; Fabio T M Costa
Journal:  Malar J       Date:  2011-05-02       Impact factor: 2.979

3.  Antifungal properties of a new terpernoid saponin and other compounds from the stem bark of Polyscias fulva Hiern (Araliaceae).

Authors:  Guy Sedar Singor Njateng; Zhizhi Du; Donatien Gatsing; Arno Rusel Nanfack Donfack; Michel Feussi Talla; Hippolyte Kamdem Wabo; Pierre Tane; Raymond Simplice Mouokeu; Xiaodong Luo; Jules-Roger Kuiate
Journal:  BMC Complement Altern Med       Date:  2015-02-15       Impact factor: 3.659

4.  Quantitative analysis of catechins in Saraca asoca and correlation with antimicrobial activity.

Authors:  Amey Shirolkar; Anjum Gahlaut; Anil K Chhillar; Rajesh Dabur
Journal:  J Pharm Anal       Date:  2013-02-09

Review 5.  The genus Caesalpinia L. (Caesalpiniaceae): phytochemical and pharmacological characteristics.

Authors:  João L Baldim Zanin; Bianca A de Carvalho; Paloma Salles Martineli; Marcelo Henrique dos Santos; João Henrique G Lago; Patrícia Sartorelli; Cláudio Viegas; Marisi G Soares
Journal:  Molecules       Date:  2012-06-29       Impact factor: 4.411

6.  Facile Syntheses and Molecular-Docking of Novel Substituted 3,4-Dimethyl-1H-pyrrole-2-carboxamide/carbohydrazide Analogues with Antimicrobial and Antifungal Properties.

Authors:  Jitendra D Bhosale; Rajesh Dabur; Gopal P Jadhav; R S Bendre
Journal:  Molecules       Date:  2018-04-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.